Cohort feasibility before you write the protocol.
Site-level patient cohort estimates by ICD-10, drug class, and geography. Built for small and mid CROs and patient-recruitment shops who need an answer in 90 seconds, not a six-figure Optum engagement six weeks out. Aggregate counts only, no PHI, BAA- ready. Pre-configured Scope template, fully editable.
Cardio + T2D + GLP-1 candidates
- E11, Type 2 diabetes mellitus
- I50, Heart failure
- GLP-1 RA (existing therapy)
- Z34, Pregnancy
TX, FL, CA, NY, PA
Sample only. Live runs return your protocol's specific cohort and time window. Aggregate counts only, cell-size floored at 11.
When IQVIA / Optum is overkill
Full RWE engagements run $50K to $500K and take weeks. Scope's feasibility template runs in 90 seconds and costs nothing on the free tier, perfect for protocol triage and pitch decks. Use Scriptlane to qualify which protocols are worth a full RWE study.
When a syndicated report won't cut it
Off-the-shelf Optum or Symphony reports are stale by the time you read them. Scope queries against the live EHR partner network and returns site-level granularity, not just nationwide totals. Edit the template and re-run as your protocol evolves.